Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of prazosin and doxazosin on yohimbine-induced reinstatement of alcohol seeking in rats
Douglas Funk, Kathleen M. Coen, Sahar Tamadon, et al.
Psychopharmacology (2016) Vol. 233, Iss. 11, pp. 2197-2207
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 112
Noradrenergic targets for the treatment of alcohol use disorder
Carolina L. Haass‐Koffler, Robert M. Swift, Lorenzo Leggio
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1625-1634
Open Access | Times Cited: 109
The intersection of stress and reward: BNST modulation of aversive and appetitive states
Sarah S. Ch’ng, Jingjing Fu, Robyn M. Brown, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 87, pp. 108-125
Closed Access | Times Cited: 103
Medications for alcohol use disorders: An overview
Mohammed Akbar, Mark Egli, Young‐Eun Cho, et al.
Pharmacology & Therapeutics (2017) Vol. 185, pp. 64-85
Open Access | Times Cited: 86
Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder
Tracy L. Simpson, Andrew J. Saxon, Cynthia A. Stappenbeck, et al.
American Journal of Psychiatry (2018) Vol. 175, Iss. 12, pp. 1216-1224
Open Access | Times Cited: 72
Common neurocircuitry mediating drug and fear relapse in preclinical models
Travis D. Goode, Stephen Maren
Psychopharmacology (2018) Vol. 236, Iss. 1, pp. 415-437
Open Access | Times Cited: 68
A balancing act: the role of pro‐ and anti‐stress peptides within the central amygdala in anxiety and alcohol use disorders
Leigh C. Walker
Journal of Neurochemistry (2021) Vol. 157, Iss. 5, pp. 1615-1643
Open Access | Times Cited: 30
The effect of acute or repeated stress on the corticotropin releasing factor system in the CRH-IRES-Cre mouse: A validation study
Leigh C. Walker, Lara C. Cornish, Andrew J. Lawrence, et al.
Neuropharmacology (2018) Vol. 154, pp. 96-106
Closed Access | Times Cited: 37
Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review
Ashley Vena, Shannon L. Zandy, Roberto U. Cofresí, et al.
Pharmacology & Therapeutics (2020) Vol. 212, pp. 107573-107573
Open Access | Times Cited: 28
Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence
Jesse T. Kaye, Daniel E. Bradford, Katherine Magruder, et al.
Journal of Studies on Alcohol and Drugs (2017) Vol. 78, Iss. 3, pp. 353-371
Open Access | Times Cited: 30
Central amygdala relaxin‐3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats
Leigh C. Walker, Hanna E. Kastman, Elena Krstew, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 19, pp. 3359-3369
Open Access | Times Cited: 30
Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
Mark K. Greenwald
Neurobiology of Stress (2018) Vol. 9, pp. 84-104
Open Access | Times Cited: 29
Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease
Bárbara Paranhos Coelho, Mariana Maier Gaelzer, Fernanda dos Santos Petry, et al.
Neuroscience (2019) Vol. 404, pp. 314-325
Closed Access | Times Cited: 27
Noradrenergic tone mediates marble burying behavior after chronic stress and ethanol
Carolina R. den Hartog, Katrina Blandino, McKenzie L. Nash, et al.
Psychopharmacology (2020) Vol. 237, Iss. 10, pp. 3021-3031
Open Access | Times Cited: 27
Cocaine and amphetamine regulated transcript (CART) signalling in the central nucleus of the amygdala modulates stress-induced alcohol seeking
Leigh C. Walker, Lexi J. Hand, Bethany Letherby, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 2, pp. 325-333
Open Access | Times Cited: 25
Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors
Elena M. Vazey, Carolina R. den Hartog, David E. Moorman
Handbook of experimental pharmacology (2018), pp. 239-260
Open Access | Times Cited: 25
Brain-wide mapping of c-fos expression in the single prolonged stress model and the effects of pretreatment with ACH-000029 or prazosin
Hátylas Azevedo, Marcos Antonio Ferreira, Alessandra Mascarello, et al.
Neurobiology of Stress (2020) Vol. 13, pp. 100226-100226
Open Access | Times Cited: 22
Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma
Anne Marije Kaag, Liesbeth Reneman, Judith R. Homberg, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 21
Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders
Leigh C. Walker, Andrew J. Lawrence
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 8, pp. 677-690
Closed Access | Times Cited: 18
Pattern of neural activation following yohimbine‐induced reinstatement of alcohol seeking in rats
Leigh C. Walker, Hanna E. Kastman, Andrew J. Lawrence
European Journal of Neuroscience (2019) Vol. 51, Iss. 3, pp. 706-720
Open Access | Times Cited: 16
Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies
Dallece E. Curley, Talia R. Vasaturo-Kolodner, Nazzareno Cannella, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 12, pp. 2111-2122
Open Access | Times Cited: 9
Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants
Bruk Getachew, Sheketha R. Hauser, Antonei B. Csòka, et al.
Drug and Alcohol Dependence (2017) Vol. 175, pp. 133-139
Open Access | Times Cited: 14
Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder
Terril L. Verplaetse, Elizabeth Ralevski, Walter Roberts, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 4, pp. 741-746
Open Access | Times Cited: 12
Evaluation of the effect of doxasozin and zonisamide on voluntary ethanol intake in mice that experienced chronic intermittent ethanol exposure and stress
Marcelo F. Lopez, Sarah E. Reasons, Benjamin Carper, et al.
Alcohol (2020) Vol. 89, pp. 37-42
Open Access | Times Cited: 9
Acute prazosin administration does not reduce stressor reactivity in healthy adults
Jesse T. Kaye, Gaylen Fronk, Aleksandra Zgierska, et al.
Psychopharmacology (2019) Vol. 236, Iss. 11, pp. 3371-3382
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top